TR
Thomas D. Reed
Chief Science Officer

Thomas D. Reed insider trades: Intrexon (XON) stock buys and sales

Chief Science Officer, Intrexon Last trade Jan 6, 2020 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2013
1
Company
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 6, 2020XON↓ Sell$32K
Jan 3, 2020XON↓ Sell$17K
Jan 2, 2020XON↓ Sell$20K
Oct 1, 2019XON↓ Sell$20K
Jul 1, 2019XON↓ Sell$27K
Mar 5, 2019XON↓ Sell$884K
Mar 4, 2019XON↓ Sell$70K
Jan 3, 2019XON↓ Sell$21K
Dec 31, 2018XON↓ Sell$191K
May 13, 2014XON↑ Buy$10K
Aug 13, 2013XON↑ Buy$29K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas D. Reed's insider trades

Thomas D. Reed is Chief Science Officer at Intrexon (XON). Since Aug 13, 2013, Thomas has reported 2 open-market purchases worth $39K and 9 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (8 filings), grants and awards (6 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.